Want to see HIT full AI Analyst Report?
HIT Stock Chart & Stats
$1.01
$0.00(0.00%)
At close: 4:00 PM EDT
$1.01
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$0.65 - $4.02
Previous Close$5.45
Volume11.84K
Average Volume (3M)251.84K
Market Cap
$48.27M
Enterprise Value$57.12
Total Cash (Recent Filing)$6.51M
Total Debt (Recent Filing)$102.94K
Price to Earnings (P/E)―
Beta1.42
Next Earnings
Nov 16, 2026EPS Estimate
-0.05Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.07
Shares Outstanding53,702,650
10 Day Avg. Volume662,995
30 Day Avg. Volume251,842
Financial Highlights & Ratios
PEG Ratio1.27
Price to Book (P/B)5.19
Price to Sales (P/S)2.66
P/FCF Ratio-1.58K
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda>-0.01
Forecast
1Y Price Target
$3.50Price Target Upside246.53% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)-0.11
Revenue Forecast (FY)$39.65M
Bulls Say, Bears Say
Bulls Say
Very Low LeverageNear-zero leverage gives Health In Tech flexibility to fund product development and commercial expansion without substantial debt-service demands. A solid equity base also improves resilience if operating losses persist, allowing management to pursue growth initiatives while limiting balance-sheet risk over the next several quarters.
AI Platform And Distribution ExpansionThe HitRix launch strengthens the company’s technology proposition by extending its marketplace into large-group self-funded insurance and integrating with existing infrastructure. Combined with a growing partner network, broader adoption could improve distribution reach, workflow efficiency, data generation, and long-term platform scale.
Contracted Revenue VisibilityA substantial contracted revenue base provides better forward visibility than relying only on new bookings each quarter. Scheduled recognition across the second half of 2026 and into 2027 can support planning, validate customer demand, and provide a foundation for future growth as additional pipeline converts.
Bears Say
Profitability And Cash-flow DeteriorationThe shift from prior-year profitability to a TTM net loss and negative operating and free cash flow weakens internally generated funding. If losses continue while the company invests in products and distribution, management may face tighter financial flexibility and greater pressure to improve margins or secure additional capital.
Reduced 2026 Revenue OutlookThe lower 2026 outlook indicates that commercialization, rate stabilization, and expanded carrier capacity are taking longer to contribute than previously expected. This creates a transitional earnings profile, delays the benefits of recent investments, and increases execution risk while management works toward larger growth drivers from 2027 onward.
Working-capital And Margin PressureThe sharp increase in receivable days can tie up cash and make reported growth less supportive of near-term liquidity. At the same time, the expected 45%–50% gross-margin range leaves less room to absorb partner economics, distribution expansion, and operating investment, complicating the path back to sustainable profitability.
Health In Tech, Inc. Class A News
HIT FAQ
What was Health In Tech, Inc. Class A’s price range in the past 12 months?
Health In Tech, Inc. Class A lowest stock price was $0.65 and its highest was $4.02 in the past 12 months.
What is Health In Tech, Inc. Class A’s market cap?
Health In Tech, Inc. Class A’s market cap is $48.27M.
When is Health In Tech, Inc. Class A’s upcoming earnings report date?
Health In Tech, Inc. Class A’s upcoming earnings report date is Nov 16, 2026 which is in 44 days.
How were Health In Tech, Inc. Class A’s earnings last quarter?
Health In Tech, Inc. Class A released its earnings results on Aug 13, 2026. The company reported -$0.04 earnings per share for the quarter, missing the consensus estimate of -$0.027 by -$0.013.
Is Health In Tech, Inc. Class A overvalued?
According to Wall Street analysts Health In Tech, Inc. Class A’s price is currently Undervalued.
Does Health In Tech, Inc. Class A pay dividends?
Health In Tech, Inc. Class A does not currently pay dividends.
What is Health In Tech, Inc. Class A’s EPS estimate?
Health In Tech, Inc. Class A’s EPS estimate is -0.05.
How many shares outstanding does Health In Tech, Inc. Class A have?
Health In Tech, Inc. Class A has 53,702,650 shares outstanding.
What happened to Health In Tech, Inc. Class A’s price movement after its last earnings report?
Health In Tech, Inc. Class A reported an EPS of -$0.04 in its last earnings report, missing expectations of -$0.027. Following the earnings report the stock price went down -5.189%.
Which hedge fund is a major shareholder of Health In Tech, Inc. Class A?
Currently, no hedge funds are holding shares in HIT
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Health In Tech, Inc. Class A Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$3.50 (246.53% Upside)
$3.50 (246.53% Upside)
Insider Transactions
Sold Shares
Worth $26.9K over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-77.69%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
39.00%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Health In Tech, Inc. Class A
Health In Tech, Inc. operates as a cutting-edge insurance technology provider. The company delivers a range of specialized insurance solutions for smaller enterprises, such as value-based pricing strategies, group insurance captives, localized community health plans, and collective association health programs. Additionally, it offers the enhanced "do it yourself" benefit system (eDIYBS), a cloud-based SaaS platform engineered to efficiently generate health insurance quotes for small to medium-sized businesses. Health In Tech further supports healthcare administration with its "health intelligence" (HI) card, which streamlines the management of medical records and claims. Complementing this is the HI performance network, an extensive series of medical facilities that utilize Medicare-based reimbursement pricing. This organization was established in 2014 and its principal offices are located in Stuart, Florida.
HIT Company Deck
HIT Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call presented a balanced picture: the company highlighted meaningful forward-looking commercial traction — $32.3M contracted revenue, a $66.3M pipeline, $84M PPPV, nearly 20% YoY distribution growth, and major product/engineering milestones (HitRix launch, 3-year stabilization program). At the same time, near-term financials showed a Q2 GAAP revenue decline (-13.5%), negative adjusted EBITDA, widened AR days, and a reduced cash balance driven by carrier onboarding timing and increased investments. Management framed many negatives as timing or deliberate investments to scale the business, while reaffirming FY guidance. Given the sizable forward pipeline and product catalysts but clear short-term profitability and liquidity pressures, the call strikes a neutral tone between opportunity and execution/financial risk.View all HIT earnings summariesHIT Stock 12 Month Forecast
Average Price Target
$3.50
▲(246.53% Upside)
Technical Analysis
Ownership Overview
61.31% Insiders
1.32% Mutual Funds
5.62% Other Institutional Investors
30.34% Public Companies and
Individual Investors